04 August 2020 | News
Selling STIMULAN® and genex calcium matrices for surgical use in musculoskeletal infections, trauma, spine and foot and ankle
Image credit- Biocomposites
UK based Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, has announced that it has signed an exclusive agreement with LifeHealthcare to sell its STIMULAN® and genex products in Australia.
LifeHealthcare is one of Australia's leading providers of medical device solutions with a team of complex orthopaedic experts that focus on infection, revision arthroplasty, oncology, limb deformity, paediatrics and biologics.
The STIMULAN® Rapid Cure and STIMULAN® Kit products are truly absorbable and specifically designed to be placed at the site of infection as part of a surgeon's dead space and infection management strategies. Its unique crystal structure and properties transform outcomes in the presence of infection.
The genex platform is an innovative, versatile synthetic bone graft that supports natural healing and vanishes without a trace.